When used in TPVB for VATS, different doses of dezocine combined with ropivacaine offer distinct short-term postoperative benefits: the 0.1 mg⋅kg-1 dezocine results in faster postoperative recovery, whereas the 0.15 mg⋅kg-1 dezocine demonstrates superior postoperative analgesic efficacy and inflammation suppression. Both doses exhibited high safety profiles, providing certain references for the selection of clinical anesthesia protocols.
Gan et al. (Tue,) studied this question.